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The purpose of this study was to evaluate the relation between gender and plaque characteristics assessed by virtual histology-
intravascular ultrasound (VH-IVUS) in patients with stable angina pectoris. Preinterventional VH-IVUS image was available for
analysis in 88 men and 60 women patients. Women had signiﬁcantly smaller vessel volume (12.7 ± 3.9 versus 14.5 ± 4.2mm3/mm,
P = .01) and smaller plaque volume (8.4 ± 3.5 versus 9.7 ± 3.5mm3/mm, P = .04). However, these diﬀerences were no longer
signiﬁcant when corrected for body surface area (BSA). In VH-IVUS analysis, women had signiﬁcantly higher dense calcium when
corrected for BSA in the culprit lesion (volume: 0.32 ± 0.26 versus 0.44 ± 0.40mm3/mm/BSA, P = .03; proportion: 8.2 ± 6.1
versus 11.2 ± 7.6%, P = .009). VH-IVUS analysis of plaque components in elderly patients with stable angina showed that women
had higher calcium contents compared with men.
1.Introduction
Women diﬀer from men in coronary artery disease epi-
demiology, symptoms, pathophysiology, and clinical out-
come [1–3]. Several studies have reported that women
are associated with an increased mortality rate following
coronary interventions compared with men. The worse
outcomes in women might be partly explained by some
clinical factors such as delayed onset of disease, older age,
smaller body surface area, smaller vessel, and comorbidities.
However, whether women have smaller vessel and diﬀer-
ent plaque characteristics on atherosclerotic segment have
not been clearly documented. And it remains uncertain
whether plaque components of coronary stenotic lesion
diﬀer between men and women. Recently, virtual histology-
intravascular ultrasound (VH-IVUS) using spectral analysis
of the radiofrequency ultrasound backscatter signals was
introduced to clinical practice to characterize the plaque
composition [4]. The purpose of this study was to examine
the gender diﬀerences of the plaque characteristics in culprit
lesions of stable angina patients as assessed by VH-IVUS.
2. Methods
Between January 2006 and December 2006, preinterven-
tional VH-IVUS was performed in 240 patients with stable
angina undergoing elective coronary intervention. Stable
angina was deﬁned as no change in the frequency and
duration of cardiac ischemic symptoms within 4 weeks
before the intervention. In the present study, inclusion
criteria were deﬁned as follows: (1) a de novo lesion
with >75% angiographic stenosis and (2) over 60-year
old patients for matching age diﬀerence between gender.
We excluded patients with bypass graft lesions, hemodial-
ysis, acute coronary syndrome, or old myocardial infarc-
tion. Finally, 148 patients (88 men and 60 women) with
stable angina were eligible and enrolled in this study.
Written informed consent was obtained from all patients.2 International Journal of Vascular Medicine
Preinterventional IVUS images were performed after admin-
istration of nitroglycerin 200µg. A 20MHz, 3.2F, VH-IVUS
catheter (Eagle Eye Gold, Volcano Therapeutics, Rancho
Cordova, CA, USA) was placed distal to the target lesion
and was pulled back with a motorized transducer pullback
system at a rate of 0.5mm/s. A single observer who was
blinded to the clinical/angiographic ﬁndings analyzed IVUS
images of culprit segment with >50% diameter stenosis.
Manual contour detection of both the lumen and the media-
adventitia interface was performed. Volumetric data were
automatically determined by the software, a summation of
measured cross-sectional areas in all frames of the pullback
regionbasedonSimpson’s rule.Therawradiofrequencydata
was captured at the top of the R wave during auto-pullback
and reconstructed the color-coded map that classiﬁed coro-
nary plaque into 4 diﬀerent components automatically by
the software (IVUS Lab Software, Volcano Therapeutics).
And the volume and percentage of each plaque component
were also automatically calculated by the software. Fibrous
tissue was shown in green, ﬁbrofatty tissue in greenish-
yellow,densecalciuminwhite,andnecroticcoreinredbased
on mathematical autoregressive spectral analysis of IVUS
backscatter [4]. The accuracy for each plaque component
between in vivo VH-IVUS and in vitro histopathology has
been reported to be 87–97% [5]. Plasma high-sensitive C-
reactive protein (hs-CRP) was measured by ELISA using
an immunonephelometric assay kit (Dade Behring, Illinois).
Glomerular ﬁltration rate (GFR) was calculated by Modiﬁ-
cation of Diet in Renal Disease Study equation [6]. Statistical
analysis was performed with StatView (SAS Institute, Cary,
North Carolina). Continuous variables were compared by
unpaired Student’s t-test or Mann-Whitney U statistic test.
Categorical variables were compared by the chi-square
analysis.VolumetricIVUSdatawaspresentedastotalvolume
perlesionlength(mm3/mm)forcorrectingthediﬀerencesof
lesion length among the subjects. For all analyses, a P value
< .05 was deﬁned as statistically signiﬁcant.
3. Results
Women had less diabetes and had higher level of high-
density lipoprotein (Table 1). No women received hormone
replacement therapy in the present study. The quantitative
analysis of grey scale is shown in Table 2. Women had
signiﬁcantly smaller vessel volume compared with men
(women versus men; 12.7 ± 3.9 versus 14.5 ± 4.2mm3/mm,
P = .01) and smaller plaque volume (women versus men;
8.4 ± 3.5 versus 9.7 ± 3.5mm3/mm, P = .04). However,
these diﬀerences were no longer signiﬁcant when corrected
for body surface area (BSA). In VH-IVUS analysis after
correcting for BSA (Table 3), the volume and percentage of
dense calcium were signiﬁcantly higher in women compared
with men (women versus men; 0.44 ± 0.40 versus 0.32 ±
0.26mm3/mm/BSA P = .03, 11.2 ± 7.6 versus 8.2 ± 6.1 %,
P = .009). Though there was no signiﬁcant diﬀerence in the
volumeofﬁbrofattytissuebetweenwomenandmen(women
versus men; 0.50 ± 0.39 versus 0.62 ± 0.50mm3/mm/BSA,
P = .11), the percentage of ﬁbrofatty tissue was signiﬁcantly
less in women (women versus men; 12.1 ± 5.4 versus 15.1
± 8.7%, P = .03). In multivariate analysis (Table 4), gender
was the only independent factor for the percentage of dense
calcium (odds ratio = 2.5, P = .05).
4. Discussion
In the present study, using preinterventional VH-IVUS
images, women had a higher amount of calcium in the
culprit lesion plaque compared with men, though there were
no quantitative diﬀerences of plaque burden when adjusted
for body surface area.
Several studies suggest that women are associated with
an increased mortality rate following coronary interventions
compared with men, although not consistently observed
[7–10]. The worse outcomes in women might be partly
explained by some clinical factors such as older age, smaller
body surface area, and comorbidities at the time of pre-
sentation [11]. However, whether women have diﬀerent
plaque characteristics on atherosclerotic segment has not
been clearly documented. An angiographic study in patients
without visual evidence of coronary atherosclerosis has
reported that lumen size in women was smaller than in men
[12],andanautopsystudyhasreportedthatthisdiﬀerencein
coronary size is due to the mass of the heart [13]. A previous
study using grey-scale IVUS has reported that women and
men also had similar reference and plaque burden and
eccentricity [14]. Similarly, in our study, there were not any
gender-speciﬁc diﬀerences of quantitative variables such as
vessel volume and plaque volume when adjusted for body
surface area. Taken together with our results, the gender
diﬀerences of vessel size might be dependent on body size.
Coronary calciﬁed plaques presumably reﬂect the patho-
logical process of plaque formation and progression from
simple fatty streaks to complex plaques [15–17]a n da r e
associated with the long-term mortality and ischemic event
[18, 19]. The use of computed tomography for detection
of coronary artery calcium has been studied previously,
and this method could evaluate the whole coronary arteries
and nonculprit segments [20]. Whereas a study using
multidetector-row computed tomography has reported that
calcium concentration of individual calciﬁed plaque is
independent of age and sex [17], our data using VH-IVUS
showed that women have more calciﬁed plaque components
in the culprit lesion compared with men. It is diﬃcult to
distinguish between intimal atherosclerotic calciﬁcation and
medial calciﬁcation by the present imaging modality like
CT, grey-scale IVUS, and VH-IVUS. Further studies will
be needed to clarify the impact of gender diﬀerences on
atherosclerotic calciﬁcation.
Estrogen has multiple biologic eﬀects that might vary
according to the underlying state of the vasculature and
other tissue [21, 22]. A recent randomized clinical study
has reported that estrogen could reduce calciﬁed plaque
burden of coronary arteries in young menopausal women
[23]. Though there was no women who received hormone
replacement therapy in the present study, these results
might have suggested that estrogen inhibits the progression
of atherosclerosis. The biological explanations for gender
diﬀerences in cardiovascular diseases are more complex, soInternational Journal of Vascular Medicine 3
Table 1: Baseline clinical characteristics.
Men (n = 88) Women (n = 60) P value
Age, y 71 ± 67 0 ± 6. 4 7
Diabetes, n (%) 33 (38) 13 (22) .05
Hyperlipidemia, n (%) 47 (53) 45 (75) .18
Hypertension, n (%) 67 (63) 37 (62) .08
Current smoking, n (%) 41 (47) 8 (13) .0001
Family history of CAD, n (%) 17 (19) 13 (22) .69
LDL, mg/dL 112.9 ± 28.0 122.0 ± 30.7 .06
HDL, mg/dL 45.1 ± 9.4 51.6 ± 12.2 .0004
HbA1c, % 6.1 ± 1.3 5.7 ± 1.1 .06
Statin use, n (%) 29 (33) 16 (27) .52
Insulin use, n (%) 10 (11) 5 (8) .75
GFR, mL/min 65.7 ± 20.0 67.3 ± 17.2 .62
hs-CRP, mg/L 1.7 ± 1.6 2.1 ± 2.9 .89
Vessel .15
Left anterior descending 41 (47) 30 (50)
Left circumﬂex 17 (19) 17 (28)
Right coronary artery 30 (34) 12 (20)
Triple vessel disease, n (%) 25 (28) 17 (28) >.99
Lesion length, mm 22.0 ± 10.8 18.3 ± 10.8 .07
Data are presented as mean ± SD or number of patients (%). CAD: coronary artery disease; LDL: low-density lipoprotein; HDL: high-density lipoprotein;
GFR: glomerular ﬁltration rate; hs-CRP: high-sensitive C-reactive protein.
Table 2: Grey-scale IVUS analysis.
Men (n = 88) Women (n = 60) P value
Vessel volume, mm3/mm 14.5 ± 4.2 12.7 ± 3.9 .01
Lumen volume, mm3/mm 4.8 ± 1.0 4.5 ± 1.3 .07
Plaque volume, mm3/mm 9.7 ± 3.5 8.4 ± 3.5 .04
Vessel volume, mm3/mm/BSA 8.8 ± 2.6 8.5 ± 2.6 .64
Lumen volume, mm3/mm/BSA 2.9 ± 0.7 2.9 ± 0.7 .83
Plaque volume, mm3/mm/BSA 5.8 ± 2.2 5.8 ± 2.2 .81
Data are presented as mean ± SD. EEM: external elastic membrane, BSA: body surface area.
Table 3: Virtual histology-IVUS analysis.
Men (n = 88) Women (n = 60) P value
Fibrous plaque volume, mm3/mm/BSA 2.66 ± 1.58 2.33 ± 1.41 .20
Fibrofatty plaque volume, mm3/mm/BSA 0.62 ± 0.50 0.50 ± 0.39 .11
Necrotic core plaque volume, mm3/mm/BSA 0.53 ± 0.31 0.59 ± 0.37 .26
Dense calcium plaque volume, mm3/mm/BSA 0.32 ± 0.26 0.44 ± 0.40 .03
% Fibrous plaque, % 63.1 ± 9.8 61.3 ± 12.5 .09
% Fibrofatty plaque, % 15.1 ± 8.7 12.1 ± 5.4 .03
% Necrotic core, % 13.6 ± 7.2 15.4 ± 6.0 .12
% Dense calcium, % 8.2 ± 6.1 11.2 ± 7.6 .009
Data are presented as mean ± SD. BSA: body surface area.
we think that the synthesis of the underlying mechanisms
that explain these diﬀerences has been impossible.
Several limitations should be noted. This is a study with
a limited number of patients with stable angina undergoing
coronary intervention, possibly posing a risk of patient
selection bias. Our analysis included only the culprit lesions;
therefore, the results may not be applicable to other parts
of coronary arteries. The VH-IVUS technology is unable to
diﬀerentiate thrombus from other plaque are components.
Although we have investigated the patients with stable4 International Journal of Vascular Medicine
Table 4: Multivariate analysis.
OR (95% CI) P value
%D e n s e
calcium versus
Gender (women) 2.5 (0.4–4.9) .05
Diabetes 1.4 (−1.1–3.9) .28
Hyperlipidemia 0.6 (−1.7–2.9) .60
Hypertension 0.6 (−1.9–3.1) .64
Current smoking −1.8 (−4.4–0.8) .18
OR: odds ratio, CI: conﬁdence interval.
angina, there is a possibility that small thrombi in the
plaque classiﬁed into the incorrect tissue. The diﬀerences in
comorbid conditions and lipid proﬁles may have inﬂuenced
the results. In previous studies using VH-IVUS analysis,
the presence of diabetes and lower HDL level contributes to
the increment of dense calcium and necrotic core [24, 25].
Although diabetes patients were less and high-density
l i p o p r o t e i nl e v e l sw e r eh i g h e ri nw o m e n ,a b s o l u t ea n d
percentage of dense calcium volume were higher in women
compared with men. And gender was an independent factor
for the percentage of dense calcium in multivariate analysis.
Thus, we think that gender diﬀerence might contribute
to the calciﬁcation of coronary arteries independently. As
we have also excluded the patients younger than 60 years
old, these results cannot be generalized to all age groups
of women due to the diﬀerent risk proﬁle in pre- versus
postmenopausal women.
In conclusion, the present study using preinterventional
VH-IVUS images has suggested that women had more
calcium in the composition of the culprit lesion plaque
compared with men in elderly patients with stable angina.
While it is yet to be proven if the management of coronary
calciﬁcation has a signiﬁcant clinical relevance, further
studies with a gender-speciﬁc approach are necessary for the
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